ES2109190B1 - Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht - Google Patents
Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-htInfo
- Publication number
- ES2109190B1 ES2109190B1 ES9600700A ES9600700A ES2109190B1 ES 2109190 B1 ES2109190 B1 ES 2109190B1 ES 9600700 A ES9600700 A ES 9600700A ES 9600700 A ES9600700 A ES 9600700A ES 2109190 B1 ES2109190 B1 ES 2109190B1
- Authority
- ES
- Spain
- Prior art keywords
- new
- serotoninergic receptors
- affinated
- bencimidazole
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000002295 serotoninergic effect Effects 0.000 title abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- -1 AMINO Chemical class 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical group ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 239000000460 chlorine Chemical group 0.000 abstract 1
- 229910052801 chlorine Chemical group 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 206010013663 drug dependence Diseases 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001537 neural effect Effects 0.000 abstract 1
- 229910052757 nitrogen Chemical group 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 208000011117 substance-related disease Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/12—Oxygen atoms acylated by aromatic or heteroaromatic carboxylic acids, e.g. cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
NUEVOS DERIVADOS DE BENCIMIDAZOL CON AFINIDAD POR LOS RECEPTORES SEROTONINERGICOS 5-HT3/5-HT4. LA PRESENTE INVENCION TRATA DE NUEVOS COMPUESTOS DE FORMULA GENERAL I, DONDE X ES OXIGENO O NITROGENO; R ES HIDROGENO O CLORO; R'' ES HIDROGENO, NITRO O AMINO; E Y ES AZABICICLO [X.Y.Z] ALQUILO, N-ALQUILPIPERIDILO O DIALQUILAMINOALQUILO. SE DESCRIBEN LOS METODOS DE PREPARACION DE DICHOS COMPUESTOS, LOS CUALES HAN MOSTRADO UNA ELEVADA AFINIDAD POR LOS RECEPTORES SEROTONINERGICOS 5-HT3 Y/O 5-HT4, LO QUE INDICA SU INTERES DESDE EL PUNTO DE VISTA TERAPEUTICO EN EL TRATAMIENTO DE LA EMESIS PROVOCADA POR LA QUIMIOTERAPIA, Y EN EL TRATAMIENTO DE ALTERACIONES GASTROINTESTINALES Y NEURONALES, TALES COMO LA ANSIEDAD, LA PSICOSIS, LA DROGODEPENDENCIA Y LOS TRASTORNOS COGNITIVOS.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9600700A ES2109190B1 (es) | 1996-03-22 | 1996-03-22 | Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht |
| AU21607/97A AU2160797A (en) | 1996-03-22 | 1997-03-18 | Novel benzimidazol derivatives having an affinity for the serotoninergic 5-ht3/5 ht4 receptors |
| PCT/ES1997/000068 WO1997035860A1 (es) | 1996-03-22 | 1997-03-18 | Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht3/5-ht¿4? |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9600700A ES2109190B1 (es) | 1996-03-22 | 1996-03-22 | Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2109190A1 ES2109190A1 (es) | 1998-01-01 |
| ES2109190B1 true ES2109190B1 (es) | 1998-07-01 |
Family
ID=8294288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES9600700A Expired - Fee Related ES2109190B1 (es) | 1996-03-22 | 1996-03-22 | Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2160797A (es) |
| ES (1) | ES2109190B1 (es) |
| WO (1) | WO1997035860A1 (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2154605B1 (es) * | 1999-09-14 | 2001-11-16 | Univ Madrid Complutense | Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3 |
| AR036041A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen |
| AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
| CA2462453C (en) | 2001-10-02 | 2009-07-28 | Pharmacia & Upjohn Company | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| US6849620B2 (en) | 2001-10-26 | 2005-02-01 | Pfizer Inc | N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
| MXPA04004373A (es) | 2001-11-09 | 2004-08-11 | Upjohn Co | Compuestos heterociclicos condensados con fenilo azabiciclo para el tratamiento de enfermedades. |
| CA2476624A1 (en) | 2002-02-19 | 2003-08-28 | Pharmacia & Upjohn Company | Azabicyclic compounds for the treatment of disease |
| CA2476681A1 (en) | 2002-02-19 | 2003-08-28 | Bruce N. Rogers | Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease |
| ES2199086B1 (es) | 2002-07-31 | 2005-06-01 | Cepa Schwarz Pharma Sl | Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas. |
| KR20060118421A (ko) * | 2003-08-29 | 2006-11-23 | 다이노젠 파마세우티컬스, 인코포레이티드 | 위장 운동 장애의 치료에 유용한 조성물 |
| TW200533348A (en) | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
| TWI351282B (en) | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
| US7728006B2 (en) | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| SE0401969D0 (sv) * | 2004-08-02 | 2004-08-02 | Astrazeneca Ab | Piperidine derivatives |
| ATE441646T1 (de) | 2004-11-05 | 2009-09-15 | Theravance Inc | 5-ht4-rezeptoragonistenverbindungen |
| EP1807423B1 (en) | 2004-11-05 | 2009-05-20 | Theravance, Inc. | Quinolinone-carboxamide compounds |
| ATE469897T1 (de) | 2004-12-22 | 2010-06-15 | Theravance Inc | Indazolcarbonsäureamidverbindungen |
| CN101160307A (zh) | 2005-02-17 | 2008-04-09 | Amr科技公司 | 用于治疗cinv和ibs-d的苯并噁唑甲酰胺 |
| NZ560828A (en) | 2005-03-02 | 2011-01-28 | Theravance Inc | Quinolinone compounds as 5-HT4 receptor agonists |
| MY147756A (en) | 2005-05-25 | 2013-01-15 | Theravance Inc | Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
| US7256294B2 (en) | 2005-05-25 | 2007-08-14 | Theravance, Inc. | Crystalline form of a benzimidazole-carboxamide medicinal compound |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5300512A (en) * | 1992-06-24 | 1994-04-05 | G. D. Searle & Co. | Benzimidazole compounds |
| US5280028A (en) * | 1992-06-24 | 1994-01-18 | G. D. Searle & Co. | Benzimidazole compounds |
| AU7195694A (en) * | 1993-07-19 | 1995-02-20 | Fujisawa Pharmaceutical Co., Ltd. | Benzimidazole derivatives useful as dopamine receptor antagonist, 5-ht receptor agonist or alpha1 receptor antagonist |
-
1996
- 1996-03-22 ES ES9600700A patent/ES2109190B1/es not_active Expired - Fee Related
-
1997
- 1997-03-18 AU AU21607/97A patent/AU2160797A/en not_active Abandoned
- 1997-03-18 WO PCT/ES1997/000068 patent/WO1997035860A1/es not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ES2109190A1 (es) | 1998-01-01 |
| AU2160797A (en) | 1997-10-17 |
| WO1997035860A1 (es) | 1997-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2109190B1 (es) | Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht | |
| PE11898A1 (es) | Nuevos inhibidores de la farnesiltransferasa, su preparacion y los compuestos farmaceuticos que los contienen | |
| SE9904508D0 (sv) | New compounds | |
| SV1999000141A (es) | Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos ref. pc10411abcz/bb | |
| HN1999000080A (es) | Derivados de isotiazol utiles como agentes anticancerosos. | |
| UY27336A1 (es) | Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6 | |
| BR0315317A (pt) | 4-piperazinil benzenossulfonil indóis com afinidade para o receptor de 5-ht6 | |
| BR0208179A (pt) | Composto, composição farmacêutica, métodos para tratar distúrbios associados com o receptor 5-ht6, distúrbios cognitivos, distúrbios da mémoria, psicose, esquizofrenia, e ansiedade, e, uso de um composto | |
| UY26086A1 (es) | Procedimientos e intermedios para preparar compuestos anticancerosos | |
| DE69513219D1 (de) | Kondensierte heterocyclische Verbindungen, ihre Herstellung und Anwendung | |
| BR0214024A (pt) | Derivados de 1,2,4-tiadiazol como moduladores de receptor de melanocortina | |
| DE69420637D1 (de) | Tricyclische Derivate und ihre Anwendung als Krebsmittel | |
| ATE417838T1 (de) | Arylsulfonyl-derivate mit 5-ht 6-rezeptor- affinität | |
| AR004480A1 (es) | Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen | |
| ES2154605A1 (es) | Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3 | |
| IL134894A (en) | 2-substituted-1,3,4,5-tetrahydro-2h-gamma-carbolines, their preparation and pharmaceutical compositions containing them | |
| NL980015I1 (nl) | Nieuwe 2-c(2,6-dichloorfenyl)amine!fenylacetoxyacetylderivaten, werkwijze voor de bereiding ervan enhun therapeutisch gebruik. | |
| DE60209362D1 (de) | 3-substituierte chinolin-4-carbonsäureamidderivate als nk-3- und nk-2-rezeptorantagonisten | |
| GB0507601D0 (en) | Compounds | |
| DE60202942D1 (de) | Thiazolopyrimidine und deren verwendung als modulatoren der chemokinrezeptoraktivität | |
| MX9200471A (es) | N-(ariloxialquil)heteroaril-8-azabiciclo[3.2.1]octanos, compuestos intermedios y un procedimiento para su preparacion, asi como su uso en calidad de medicamentos | |
| GT200500319A (es) | Algunos metabolitos derivados de [1,4]diazepino[6,7,1-ij]quinolina y metodos para la preparacion y usos de los mismos. | |
| ES2193380T3 (es) | Dihidropiranos condesados en el anillo, procedimiento para su preparacion, asi como su utilizacion. | |
| ES2098186A1 (es) | Composiciones farmaceuticas a base de aminometilindoles para su aplicacion terapeutica como neuroprotectores en las enfermedades de parkinson y alzheimer. | |
| ES2155898T3 (es) | Derivados de azepina tetraciclica sustituidos, que presentan una afinidad por los receptores 5-ht2. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EC2A | Search report published |
Date of ref document: 19980101 Kind code of ref document: A1 Effective date: 19980101 |
|
| FD2A | Announcement of lapse in spain |
Effective date: 20160629 |